ArticleBreast cancer research : BCR2025

Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer.

Natasha B Hunter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.